Slingshot members are tracking this event:

Data from Etrasimod Optimized Activity SIP Receptor Modulator in Treating Ulcerative Colitis expected Q4 2017

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
ARNA Community voting in process
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 10, 2017
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Etrasimod, Sip Receptor Modulator, Ulcerative Colitis